Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques
Ravi Dyavar Shetty, … , Guido Silvestri, Rama Rao Amara
Ravi Dyavar Shetty, … , Guido Silvestri, Rama Rao Amara
Published April 23, 2012
Citation Information: J Clin Invest. 2012;122(5):1712-1716. https://doi.org/10.1172/JCI60612.
View: Text | PDF
Brief Report Article has an altmetric score of 7

PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques

  • Text
  • PDF
Abstract

Hyperimmune activation is a strong predictor of disease progression during pathogenic immunodeficiency virus infections and is mediated in part by sustained type I IFN signaling in response to adventitious microbial infection. The immune inhibitory receptor programmed death–1 (PD-1) regulates functional exhaustion of virus-specific CD8+ T cells during chronic infections, and in vivo PD-1 blockade has been shown to improve viral control of SIV. Here, we show that PD-1 blockade during chronic SIV infection markedly reduced the expression of transcripts associated with type I IFN signaling in the blood and colorectal tissue of rhesus macaques (RMs). The effect of PD-1 blockade on type I IFN signaling was durable and persisted even under conditions of high viremia. Reduced type I IFN signaling was associated with enhanced expression of some of the junction-associated genes in colorectal tissue and with a profound decrease in plasma LPS levels, suggesting a possible repair of gut-associated junctions and decreased microbial translocation into the blood. PD-1 blockade enhanced immunity to gut-resident pathogenic bacteria, control of gut-associated opportunistic infections, and survival of SIV-infected RMs. Our results suggest PD-1 blockade as a potential novel therapeutic approach to enhance combination antiretroviral therapy by suppressing hyperimmune activation in HIV-infected individuals.

Authors

Ravi Dyavar Shetty, Vijayakumar Velu, Kehmia Titanji, Steven E. Bosinger, Gordon J. Freeman, Guido Silvestri, Rama Rao Amara

×

Total citations by year

Year: 2025 2024 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Total
Citations: 1 2 6 11 14 5 7 8 12 6 15 17 4 108
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (108)

Title and authors Publication Year
Interleukin-21 and anti-α4β7 dual therapy during ART promotes immunological and microbiome responses in SIV-infected macaques
Samuel D. Johnson, Maria Pino, Arpan Acharya, Julien A. Clain, Deepanwita Bose, Kevin Nguyen, Justin Harper, Francois Villinger, Mirko Paiardini, Siddappa Byrareddy
JCI Insight 2025
Immune restoration by TIGIT blockade is insufficient to control chronic SIV infection
Webb GM, Pessoa CT, McCullen AJ, Hwang JM, Humkey MC, Thormin-Odum R, Kukula KA, Smedley J, Fischer M, Sciurba J, Bochart RM, Shriver-Munsch C, Ndhlovu LC, Sacha JB
Journal of virology 2024
Immune checkpoint inhibitors in infectious disease
King HA, Lewin SR
Immunological Reviews 2024
PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques
Vijayakumar Velu, Kehmia Titanji, Hasan Ahmad, Ravi D Shetty, Lakshmi Chennareddi, Gordon Freeman, Rafi Ahmed, Rama Amara
Proceedings of the National Academy of Sciences 2022
Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities
A Timofeeva, S Sedykh, G Nevinsky
Human vaccines 2022
Expression Profile and Biological Role of Immune Checkpoints in Disease Progression of HIV/SIV Infection
Y Sun, J Xue
Viruses 2022
Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury
Gunasekaran M, Mishra R, Saha P, Morales D, Cheng WC, Jayaraman AR, Hoffman JR, Davidson L, Chen L, Shah AM, Bittle G, Fu X, Tulshyan A, Abdullah M, Kingsbury T, Civin C, Yang P, Davis ME, Bolli R, Hare JM, Sharma S, Kaushal S
iScience 2022
Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function
Brunet-Ratnasingham E, Morou A, Dubé M, Niessl J, Baxter AE, Tastet O, Brassard N, Ortega-Delgado G, Charlebois R, Freeman GJ, Tremblay C, Routy JP, Kaufmann DE
EBioMedicine 2022
Cellular Senescence in Immunity against Infections
Marrella V, Facoetti A, Cassani B
International journal of molecular sciences 2022
Impact of Anti–PD-1 and Anti–CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study
TA Rasmussen, L Rajdev, A Rhodes, A Dantanarayana, S Tennakoon, S Chea, T Spelman, S Lensing, R Rutishauser, S Bakkour, M Busch, JD Siliciano, RF Siliciano, MH Einstein, DP Dittmer, E Chiao, SG Deeks, C Durand, SR Lewin
Clinical Infectious Diseases 2021
Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
AB López, MA Penedo, T Rivera-Baltanas, D Pérez-Rodríguez, D Alonso-Crespo, C Fernández-Pereira, JM Olivares, RC Agís-Balboa
Biomedicines 2021
Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis
SD Johnson, OA Olwenyi, N Bhyravbhatla, M Thurman, K Pandey, EA Klug, M Johnston, SR Dyavar, A Acharya, AT Podany, CV Fletcher, M Mohan, K Singh, SN Byrareddy
World journal of gastroenterology : WJG 2021
PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8 + T cells in lymphoid tissue
SA Rahman, B Yagnik, AP Bally, KN Morrow, S Wang, TH Vanderford, GJ Freeman, R Ahmed, RR Amara
Science Immunology 2021
Critical Role of Zinc Transporter (ZIP8) in Myeloid Innate Immune Cell Function and the Host Response against Bacterial Pneumonia
SC Hall, DR Smith, SR Dyavar, TA Wyatt, DR Samuelson, KL Bailey, DL Knoell
Journal of immunology (Baltimore, Md. : 1950) 2021
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
SR Dyavar, R Singh, R Emani, GP Pawar, VD Chaudhari, AT Podany, SN Avedissian, CV Fletcher, DB Salunke
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2021
Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways
J Li, HH Huang, B Tu, MJ Zhou, W Hu, YL Fu, XY Li, T Yang, JW Song, X Fan, YM Jiao, RN Xu, JY Zhang, CB Zhou, JH Yuan, C Zhen, M Shi, FS Wang, C Zhang
Frontiers in immunology 2021
In-vitro Immunomodulatory activity of Azadirachta indica A.Juss. Ethanol: water mixture against HIV associated chronic CD4+ T-cell activation/ exhaustion
OA Olwenyi, B Asingura, P Naluyima, GU Anywar, J Nalunga, M Nakabuye, M Semwogerere, B Bagaya, F Cham, A Tindikahwa, F Kiweewa, EZ Lichter, AT Podany, CV Fletcher, SN Byrareddy, H Kibuuka
2021
PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques
KD Kauffman, S Sakai, NE Lora, S Namasivayam, PJ Baker, O Kamenyeva, TW Foreman, CE Nelson, D Oliveira-de-Souza, CL Vinhaes, Z Yaniv, CS Arleham, A Sette, GJ Freeman, R Moore, A Sher, KD Mayer-Barber, BB Andrade, J Kabat, LE Via, DL Barber
Science Immunology 2021
Mathematical modeling of N-803 treatment in SIV-infected non-human primates
JW Cody, AL Ellis-Connell, SL OConnor, E Pienaar, RM Ribeiro
PLoS computational biology 2021
Disease Progression in Children With Perinatal Human Immunodeficiency Virus Correlates With Increased PD-1+ CD8 T Cells That Coexpress Multiple Immune Checkpoints
Tailor J, Foldi J, Generoso M, McCarty B, Alankar A, Kilberg M, Mwamzuka M, Marshed F, Ahmed A, Liu M, Borkowsky W, Unutmaz D, Khaitan A
The Journal of Infectious Diseases 2021
An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics
S Wang, Q Zhang, H Hui, K Agrawal, MA Karris, TM Rana
Emerging Microbes & Infections 2020
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption
J Harper, S Gordon, CN Chan, H Wang, E Lindemuth, C Galardi, SD Falcinelli, SL Raines, JL Read, K Nguyen, CS McGary, M Nekorchuk, K Busman-Sahay, J Schawalder, C King, M Pino, L Micci, B Cervasi, S Jean, A Sanderson, B Johns, AA Koblansky, H Amrine-Madsen, J Lifson, DM Margolis, G Silvestri, KJ Bar, D Favre, JD Estes, M Paiardini
Nature Medicine 2020
The Potential of Immune Modulation in Therapeutic HIV-1 Vaccination
N Seddiki, F Picard, L Dupaty, Y Lévy, V Godot
Human vaccines 2020
Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure
S Vigano, S Bobisse, G Coukos, M Perreau, A Harari
Frontiers in immunology 2020
Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates
BJ Rust, LS Kean, L Colonna, KE Brandenstein, NH Poole, W Obenza, MR Enstrom, CR Maldini, GI Ellis, CM Fennessey, ML Huang, BF Keele, KR Jerome, JL Riley, HP Kiem, CW Peterson
Blood 2020
The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?
H Chen, M Moussa, M Catalfamo
Frontiers in immunology 2020
Combination rhIL-15 and Anti-PD-L1 (Avelumab) Enhances HIVGag-Specific CD8 T-Cell Function
BA Goshu, H Chen, M Moussa, J Cheng, M Catalfamo
The Journal of Infectious Diseases 2020
T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy:
BJ Macatangay, RT Gandhi, RB Jones, DK Mcmahon, CM Lalama, RJ Bosch, JC Cyktor, AS Thomas, L Borowski, SA Riddler, E Hogg, E Stevenson, JJ Eron, JW Mellors, CR Rinaldo
AIDS 2020
Transcriptomic approach predicts a major role for transforming growth factor beta type 1 pathway in L‐Dopa ‐induced dyskinesia in parkinsonian rats
SR Dyavar, LF Potts, G Beck, BL Shetty, B Lawson, AT Podany, CV Fletcher, RR Amara, SM Papa
Genes, brain, and behavior 2020
Pattern Recognition Receptor Ligands as an Emerging Therapeutic Agent for Latent HIV-1 Infection
S Takahama, T Yamamoto
Frontiers in Cellular and Infection Microbiology 2020
Overexpression of CD6 and PD-1 Identifies Dysfunctional CD8+ T-Cells During Chronic SIV Infection of Rhesus Macaques
G Enyindah-Asonye, A Nwankwo, MA Rahman, R Hunegnaw, C Hogge, SH Hait, EJ Ko, T Hoang, M Robert-Guroff
Frontiers in immunology 2020
Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics
SR Dyavar, TM Mykris, LC Winchester, KK Scarsi, CV Fletcher, AT Podany
Scientific Reports 2020
Functional MAIT Cells Are Associated With Reduced Simian–Human Immunodeficiency Virus Infection
A Murugesan, C Ibegbu, TM Styles, AT Jones, U Shanmugasundaram, PB Reddy, SJ Rahman, P Saha, M Vijay-Kumar, EM Shankar, RR Amara, V Velu
Frontiers in immunology 2020
Investigational drugs with dual activity against HBV and HIV (Review)
S Sun, Q Yang, Y Sheng, Y Fu, C Sun, C Deng
Experimental and therapeutic medicine 2020
Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology
G Mylvaganam, AG Yanez, M Maus, BD Walker
Frontiers in immunology 2019
CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy
F Perdomo-Celis, NA Taborda, MT Rugeles
Frontiers in immunology 2019
rhIL-15 and anti-PD-L1 combination therapy expands a CXCR3+PD1-/low CD8 T cell subset in SIV-infected rhesus macaques
P Chen, H Chen, M Moussa, J Cheng, T Li, J Qin, JD Lifson, MC Sneller, L Krymskaya, S Godin, HC Lane, M Catalfamo
The Journal of Infectious Diseases 2019
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection
Y Wang, YR Chung, S Eitzinger, N Palacio, S Gregory, M Bhattacharyya, P Penaloza-MacMaster, CM Walker
PLoS pathogens 2019
Between a shock and a hard place: challenges and developments in HIV latency reversal
JM Zerbato, HV Purves, SR Lewin, TA Rasmussen
Current Opinion in Virology 2019
Combination Anti-PD-1 and Anti-Retroviral Therapy Provides Therapeutic Benefit Against SIV
Geetha Mylvaganam, Lynette Chea, Gregory Tharp, Sakeenah Hicks, Vijayakumar Velu, Smita Iyer, Claire Deleage, Jacob Estes, Steven E. Bosinger, Gordon Freeman, Rafi Ahmed, Rama Rao Amara
JCI Insight 2018
Inhibition of p38 MAPK in combination with ART reduces SIV-induced immune activation and provides additional protection from immune system deterioration
O Chaudhary, V Narayan, F Lelis, B Linz, M Watkins, R Veazey, A Aldovini, SR Ross
PLoS pathogens 2018
T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses
A Saeidi, K Zandi, YY Cheok, H Saeidi, WF Wong, CY Lee, HC Cheong, YK Yong, M Larsson, EM Shankar
Frontiers in immunology 2018
Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection
M Sperk, R Domselaar, U Neogi
International journal of molecular sciences 2018
The Roles of Coinhibitory Receptors in Pathogenesis of Human Retroviral Infections
K Yasuma-Mitobe, M Matsuoka
Frontiers in immunology 2018
Nanotechnology approaches to eradicating HIV reservoirs
S Cao, KA Woodrow
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 2018
Normalization of cell associated antiretroviral drug concentrations with a novel RPP30 droplet digital PCR assay
SR Dyavar, Z Ye, SN Byrareddy, KK Scarsi, LC Winchester, JA Weinhold, CV Fletcher, AT Podany
Scientific Reports 2018
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
K Catakovic, E Klieser, D Neureiter, R Geisberger
Cell Communication and Signaling 2017
Purging Exhausted Virus-Specific CD8 T Cell Phenotypes by Somatic Cell Reprogramming
J Chan, PY Kim, E Kranz, Y Nagaoka, YJ Lee, J Wen, HJ Elsaesser, M Qin, DG Brooks, GE Ringpis, IS Chen, M Kamata
AIDS Research and Human Retroviruses 2017
The innate immune receptor MDA5 limits rotavirus infection but promotes cell death and pancreatic inflammation
Y Dou, HC Yim, CD Kirkwood, BR Williams, AJ Sadler
The EMBO Journal 2017
CD8 T-cell regulation by T regulatory cells and the programmed cell death protein 1 pathway
P Penaloza-MacMaster
Immunology 2017
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
CL Gay, RJ Bosch, J Ritz, JM Hataye, E Aga, RL Tressler, SW Mason, CK Hwang, DM Grasela, N Ray, JC Cyktor, JM Coffin, EP Acosta, RA Koup, JW Mellors, JJ Eron
The Journal of Infectious Diseases 2017
HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions
J Foldi, L Kozhaya, B McCarty, M Mwamzuka, F Marshed, T Ilmet, M Kilberg, A Kravietz, A Ahmed, W Borkowsky, D Unutmaz, A Khaitan
The Journal of Infectious Diseases 2017
Immune checkpoint blockade in infectious diseases
MN Wykes, SR Lewin
Nature Reviews Immunology 2017
Anti-Bovine Programmed Death-1 Rat–Bovine Chimeric Antibody for Immunotherapy of Bovine Leukemia Virus Infection in Cattle
T Okagawa, S Konnai, A Nishimori, N Maekawa, R Ikebuchi, S Goto, C Nakajima, J Kohara, S Ogasawara, Y Kato, Y Suzuki, S Murata, K Ohashi
Frontiers in immunology 2017
HIV-specific CD8+ T cells and HIV eradication
Brad Jones, Bruce Walker
Journal of Clinical Investigation 2016
Reversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical Research
R Ponte, V Mehraj, P Ghali, A Couëdel-Courteille, R Cheynier, JP Routy
EBioMedicine 2016
Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti–programed death-ligand 1 (Avelumab)
AL Gill, SA Green, S Abdullah, CL Saout, S Pittaluga, H Chen, R Turnier, J Lifson, S Godin, J Qin, MC Sneller, JM Cuillerot, H Sabzevari, HC Lane, M Catalfamo
AIDS 2016
Translocation of microbes and changes of immunocytes in the gut of rapid- and slow-progressor Chinese rhesus macaques infected with SIVmac239
LT Zhang, RR Tian, HY Zheng, GQ Pan, XY Tuo, HJ Xia, XS Xia, W Pang, YT Zheng
Immunology 2016
Type I interferons in viral control and immune regulation
JR Teijaro
Current Opinion in Virology 2016
Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses
J R Teijaro
Advances in immunology 2016
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
J Attanasio, EJ Wherry
Immunity 2016
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
V Vieillard, S Gharakhanian, O Lucar, C Katlama, O Launay, B Autran, RH Fang, J Crouzet, RL Murphy, P Debré
Oncotarget 2016
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation:
AS Zevin, L McKinnon, A Burgener, NR Klatt
Current Opinion in HIV and AIDS 2016
The immunosuppressive domain of the transmembrane envelope protein gp41 of HIV-1 binds to human monocytes and B cells
M Mühle, T Kroniger, K Hoffmann, J Denner
Immunologic Research 2016
TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection
GM Chew, T Fujita, GM Webb, BJ Burwitz, HL Wu, JS Reed, KB Hammond, KL Clayton, N Ishii, M Abdel-Mohsen, T Liegler, BI Mitchell, FM Hecht, M Ostrowski, CM Shikuma, SG Hansen, M Maurer, AJ Korman, SG Deeks, JB Sacha, LC Ndhlovu, G Silvestri
PLoS pathogens 2016
Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques
ER Roberts, DG Carnathan, H Li, GM Shaw, G Silvestri, MR Betts, DT Evans
PLoS pathogens 2016
CD4 T Cell Depletion Substantially Augments the Rescue Potential of PD-L1 Blockade for Deeply Exhausted CD8 T Cells
P Penaloza-MacMaster, NM Provine, E Blass, DH Barouch
Journal of immunology (Baltimore, Md. : 1950) 2015
PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia
C Peligero, J Argilaguet, R Güerri-Fernandez, B Torres, C Ligero, P Colomer, M Plana, H Knobel, F García, A Meyerhans, G Silvestri
PLoS pathogens 2015
Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options
V Velu, RD Shetty, M Larsson, EM Shankar
Retrovirology 2015
Lipopolysaccharide Increases Immune Activation and Alters T Cell Homeostasis in SHIV B’WHU Chronically Infected Chinese Rhesus Macaque
GH Zhang, RD Wu, HY Zheng, XL Zhang, MX Zhang, RR Tian, GM Liu, W Pang, YT Zheng
Journal of Immunology Research 2015
Next-Generation mRNA Sequencing Reveals Pyroptosis-Induced CD4 + T Cell Death in Early Simian Immunodeficiency Virus-Infected Lymphoid Tissues
W Lu, AJ Demers, F Ma, G Kang, Z Yuan, Y Wan, Y Li, J Xu, M Lewis, Q Li, G Silvestri
Journal of virology 2015
Lack of the programmed death-1 receptor renders host susceptible to enteric microbial infection through impairing the production of the mucosal natural killer cell effector molecules
S Solaymani-Mohammadi, O Lakhdari, I Minev, S Shenouda, BF Frey, R Billeskov, SM Singer, JA Berzofsky, L Eckmann, MF Kagnoff
Journal of leukocyte biology 2015
Dysregulation of multiple inflammatory molecules in lymph node and ileum of macaques during RT-SHIV infection with or without antiretroviral therapy
Z Ambrose, C Kline, P Polacino, SL Hu
Journal of Medical Primatology 2014
HIV-1 Latency: An Update of Molecular Mechanisms and Therapeutic Strategies
A Battistini, M Sgarbanti
Viruses 2014
Dendritic cells in progression and pathology of HIV infection
O Manches, D Frleta, N Bhardwaj
Trends in Immunology 2014
Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection
H Cho, M Kikuchi, Y Li, N Nakamoto, VK Amorosa, ME Valiga, KM Chang
Frontiers in immunology 2014
Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?
A Saez-Cirion, B Jacquelin, F Barre-Sinoussi, M Muller-Trutwin
Philosophical Transactions of the Royal Society B: Biological Sciences 2014
Tissue-Expressed B7-H1 Critically Controls Intestinal Inflammation
L Scandiuzzi, K Ghosh, KA Hofmeyer, YM Abadi, E Lázár-Molnár, EY Lin, Q Liu, H Jeon, SC Almo, L Chen, SG Nathenson, X Zang
Cell Reports 2014
Multiple Low-Dose Challenges in a Rhesus Macaque AIDS Vaccine Trial Result in an Evolving Host Response That Affects Protective Outcome
C Selinger, N Strbo, L Gonzalez, L Aicher, JM Weiss, GL Law, RE Palermo, M Vaccari, G Franchini, ER Podack, MG Katze
Clinical and vaccine immunology : CVI 2014
Expansion of Dysfunctional Tim-3-Expressing Effector Memory CD8+ T Cells during Simian Immunodeficiency Virus Infection in Rhesus Macaques
T Fujita, BJ Burwitz, GM Chew, JS Reed, R Pathak, E Seger, KL Clayton, JM Rini, MA Ostrowski, N Ishii, MJ Kuroda, SG Hansen, JB Sacha, LC Ndhlovu
Journal of immunology (Baltimore, Md. : 1950) 2014
Diminished Viral Control during Simian Immunodeficiency Virus Infection Is Associated with Aberrant PD-1hi CD4 T Cell Enrichment in the Lymphoid Follicles of the Rectal Mucosa
GH Mylvaganam, V Velu, JJ Hong, S Sadagopal, S Kwa, R Basu, B Lawson, F Villinger, RR Amara
Journal of immunology (Baltimore, Md. : 1950) 2014
Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway
NL Bowers, ES Helton, RP Huijbregts, PA Goepfert, SL Heath, Z Hel
PLoS pathogens 2014
Animal models for viral infection and cell exhaustion:
CS McGary, G Silvestri, M Paiardini
Current Opinion in HIV and AIDS 2014
Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease:
LR Cockerham, V Jain, E Sinclair, DV Glidden, W Hartogenesis, H Hatano, PW Hunt, JN Martin, CD Pilcher, R Sekaly, JM McCune, FM Hecht, SG Deeks
AIDS 2014
Negative regulation by PD-L1 during drug-specific priming of IL-22-secreting T cells and the influence of PD-1 on effector T cell function
A Gibson, M Ogese, A Sullivan, E Wang, K Saide, P Whitaker, D Peckham, L Faulkner, BK Park, DJ Naisbitt
Journal of immunology (Baltimore, Md. : 1950) 2014
HIV-1 Tat Protein Induces PD-L1 (B7-H1) Expression on Dendritic Cells through Tumor Necrosis Factor Alpha- and Toll-Like Receptor 4-Mediated Mechanisms
R Planes, L BenMohamed, K Leghmari, P Delobel, J Izopet, E Bahraoui
Journal of virology 2014
STAT3, STAT4, NFATc1, and CTCF Regulate PD-1 through Multiple Novel Regulatory Regions in Murine T Cells
JW Austin, P Lu, P Majumder, R Ahmed, JM Boss
Journal of immunology (Baltimore, Md. : 1950) 2014
Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients
Z Zhang, J Fu, X Xu, S Wang, R Xu, M Zhao, W Nie, X Wang, J Zhang, T Li, L Su, FS Wang
AIDS 2013
Immune Activation and Collateral Damage in AIDS Pathogenesis
F Miedema, MD Hazenberg, K Tesselaar, D Baarle, RJ de Boer, JA Borghans
Frontiers in immunology 2013
Immune activation and HIV persistence: implications for curative approaches to HIV infection
NR Klatt, N Chomont, DC Douek, SG Deeks
Immunological Reviews 2013
Dendritic cell dysregulation during HIV-1 infection
E Miller, N Bhardwaj
Immunological Reviews 2013
Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1
A Boasso
Scientifica 2013
Combined approaches for HIV cure
DM Margolis, DJ Hazuda
Current Opinion in HIV and AIDS 2013
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
MJ Fuller, B Callendret, B Zhu, GJ Freeman, DL Hasselschwert, W Satterfield, AH Sharpe, LB Dustin, CM Rice, A Grakoui, R Ahmed, CM Walker
Proceedings of the National Academy of Sciences 2013
Strength of PD-1 signaling differentially affects T-cell effector functions
F Wei, S Zhong, Z Ma, H Kong, A Medvec, R Ahmed, GJ Freeman, M Krogsgaard, JL Riley
Proceedings of the National Academy of Sciences 2013
PD-1 coinhibitory signals: The link between pathogenesis and protection
DA Kulpa, M Lawani, A Cooper, Y Peretz, J Ahlers, RP Sékaly
Seminars in Immunology 2013
Microbial translocation, immune activation, and HIV disease
NR Klatt, NT Funderburg, JM Brenchley
Trends in Microbiology 2013
An Altered Maturation and Adhesion Phenotype of Dendritic Cells in Diseased Individuals Compared to Asymptomatic Carriers of Human T Cell Leukemia Virus Type 1
SL Manuel, M Sehgal, ZK Khan, JJ Goedert, MR Betts, P Jain
AIDS Research and Human Retroviruses 2013
Programmed Death 1 Lives Up to Its Reputation in Active Tuberculosis
SB Sable
The Journal of Infectious Diseases 2013
T-cell reconstitution during murine acquired immunodeficiency syndrome (MAIDS) produces neuroinflammation and mortality in animals harboring opportunistic viral brain infection
MB Mutnal, SJ Schachtele, S Hu, JR Lokensgard
Journal of Neuroinflammation 2013
Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection
JJ Hong, PK Amancha, K Rogers, AA Ansari, F Villinger
PloS one 2013
Induction of SerpinB2 and Th1/Th2 modulation by SerpinB2 during lentiviral infections in vivo
LD Major, TS Partridge, J Gardner, SJ Kent, R Rose, A Suhrbier, WA Schroder
PloS one 2013
In Vivo Blockade of the Programmed Cell Death-1 Pathway Using Soluble Recombinant PD-1-Fc Enhances CD4+ and CD8+ T Cell Responses but Has Limited Clinical Benefit
PK Amancha, JJ Hong, K Rogers, AA Ansari, F Villinger
Journal of immunology (Baltimore, Md. : 1950) 2013
Expansion or Depletion of T Follicular Helper cells During HIV Infection: Consequences for B cell Responses
Onabajo OO, Mattapallil JJ
Current HIV research 2013
Attacking the HIV Reservoir from the Immune and Viral Perspective
M Massanella, J Martinez-Picado, J Blanco
Current HIV/AIDS Reports 2012
Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?
G Vanham, EV Gulck
Retrovirology 2012
Nonhuman Primate Models for HIV Cure Research
C Apetrei, I Pandrea, JW Mellors
PLoS pathogens 2012
Enhancing immune responses to limit chronic immune activation during SIV
JD Estes
Journal of Clinical Investigation 2012

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 3 X users
Referenced in 10 patents
Highlighted by 1 platforms
102 readers on Mendeley
See more details